Leronlimab (PRO 140)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Leronlimab (PRO 140), covering 2023-03-01 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC [Phase 1, Phase 2]